Notice of Award of a Sole Source Cooperative Agreement To Fund Ministry of Health of Mozambique (MISAU), 19596 [2024-05778]
Download as PDF
<![CDATA[
19596
Federal Register / Vol. 89, No. 54 / Tuesday, March 19, 2024 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–05775 Filed 3–18–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Award of a Sole Source
Cooperative Agreement To Fund
Ministry of Health of Mozambique
(MISAU)
Summary of the Award
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces the
award(s) of approximately $10,000,000,
for Year 1 funding to MISAU. The(se)
award(s) will support the GRM through
MISAU to continue to address
Tuberculosis (TB) and human
immunodeficiency virus (HIV) as a
public health problem through the
expansion of access to quality HIV
prevention, care, and treatment services
to reduce remaining gaps among
children, adolescents, key populations
(KP) and men. Funding amounts for
years 2–5 will be set at continuation.
DATES: The period for this award will be
September 30, 2024, through September
29, 2029.
FOR FURTHER INFORMATION CONTACT:
Scott Salo, Center for Global Health,
Centers for Disease Control and
Prevention, Avenida Marginal nr 5467
Sommerschield, Distrito Municipal de
KaMpfumo Caixa Postal 783 CEP 0101–
11 Maputo, Moc
¸ambique, Telephone:
404.553.7439, E-Mail: evf1@cdc.gov.
SUPPLEMENTARY INFORMATION: The sole
source award(s) will strengthen
technical, managerial, and institutional
capacities at MISAU to optimize some
of the following approaches: youth
appropriate HIV testing services, HIVrelated DREAMS services for
Adolescent Girls and Young Women,
pre-exposure prophylaxis services,
voluntary medical male circumcision
services, cervical cancer services, and
gender-based violence services. Other
approaches include maternal and child
health services, differentiated HIV
service delivery models, and HIV and
TB services.
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:41 Mar 18, 2024
Jkt 262001
MISAU is in a unique position to
conduct this work, as it is the central
institution of public sector, which
according to the law of the Republic of
Mozambique, is responsible for the
implementation of health policy in the
public, private, and community
domains. MISAU, by law, has the
authority to lead, provide oversight,
monitor the implementation of
healthcare programs and services at
national level, and is mandated to
develop policies and guidelines, and
plan, manage, and coordinate all healthrelated activities including HIV/TB
services.
Recipient: Ministry of Health of
Mozambique (MISAU).
Purpose of the Award: The purpose of
this award is to to prepare MISAU to
sustain the gains of the national HIV
response through the development of a
measurable roadmap for sustainability
and support the Government of
Mozambique through MISAU to
continue to address HIV/TB as a public
health problem through the expansion
of access to quality HIV prevention,
care, and treatment services to reduce
remaining gaps among children,
adolescents, KP, and men.
Amount of Award: For MISAU, the
approximate year 1 funding amount will
be $10,000,000 in Federal Fiscal Year
(FYY) 2024 funds, subject to the
availability of funds. Funding amounts
for years 2–5 will be set at continuation.
Authority: This program is authorized
under Public Law 108–25 (the United
States Leadership Against HIV AIDS,
Tuberculosis and Malaria Act of 2003)
[22 U.S.C. 7601, et seq.] and Public Law
110–293 (the Tom Lantos and Henry J.
Hyde United States Global Leadership
Against HIV/AIDS, Tuberculosis, and
Malaria Reauthorization Act of 2008),
and Public Law 113–56 (PEPFAR
Stewardship and Oversight Act of 2013).
Period of Performance: The period for
this award will be September 30, 2024,
through September 29, 2029.
Dated: March 13, 2024.
Jamie Legier,
Acting Director, Office of Grants Services,
Centers for Disease Control and Prevention.
[FR Doc. 2024–05778 Filed 3–18–24; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Award of a Sole Source
Cooperative Agreement To Fund
International Union Against
Tuberculosis and Lung Disease (The
Union)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces the
award of approximately $500,000, for
Year 1 funding to The Union. The award
will continue developing and updating
Tuberculosis (TB) scientific and
programmatic resources, disseminating
TB best practices, and building TB
capacity. Funding amounts for years 2–
5 will be set at continuation.
DATES: The period for this award will be
September 30, 2024, through September
29, 2029.
FOR FURTHER INFORMATION CONTACT:
Victoria Tully, Center for Global Health,
Centers for Disease Control and
Prevention, 1600 Clifton Road, MS
US1–1 Atlanta, Georgia 30329,
Telephone: 404.718.2549, E-Mail: nts2@
cdc.gov.
SUPPLEMENTARY INFORMATION: The sole
source award will focus on developing
and updating scientific and
programmatic resources, disseminating
clinical and programmatic best
practices, and building capacity. These
activities are expected to equip health
officials, health professionals, and
health care and public health workers
with skills and knowledge based on the
latest TB recommendations.
The Union is in a unique position to
conduct this work, as it was given the
mandate: (1) to establish a Federation
amongst the national associations or
organizations engaged in the campaign
against TB, to coordinate their efforts
throughout the world, and to work in
collaboration with international
organizations to end TB disease; (2) to
organize scientific conferences and
congresses regarding TB; (3) to compare
national legislation in preventing and
controlling TB; (4) to collect
international TB statistics; (5) to
stimulate scientific and social
investigations regarding the
distribution, spread, prevention, and
treatment of TB in various countries;
and (6) to collect and distribute
SUMMARY:
E:\FR\FM\19MRN1.SGM
19MRN1
]]>Agencies
[Federal Register Volume 89, Number 54 (Tuesday, March 19, 2024)]
[Notices]
[Page 19596]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-05778]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Award of a Sole Source Cooperative Agreement To Fund
Ministry of Health of Mozambique (MISAU)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), located
within the Department of Health and Human Services (HHS), announces the
award(s) of approximately $10,000,000, for Year 1 funding to MISAU.
The(se) award(s) will support the GRM through MISAU to continue to
address Tuberculosis (TB) and human immunodeficiency virus (HIV) as a
public health problem through the expansion of access to quality HIV
prevention, care, and treatment services to reduce remaining gaps among
children, adolescents, key populations (KP) and men. Funding amounts
for years 2-5 will be set at continuation.
DATES: The period for this award will be September 30, 2024, through
September 29, 2029.
FOR FURTHER INFORMATION CONTACT: Scott Salo, Center for Global Health,
Centers for Disease Control and Prevention, Avenida Marginal nr 5467
Sommerschield, Distrito Municipal de KaMpfumo Caixa Postal 783 CEP
0101-11 Maputo, Mo[ccedil]ambique, Telephone: 404.553.7439, E-Mail:
[email protected].
SUPPLEMENTARY INFORMATION: The sole source award(s) will strengthen
technical, managerial, and institutional capacities at MISAU to
optimize some of the following approaches: youth appropriate HIV
testing services, HIV-related DREAMS services for Adolescent Girls and
Young Women, pre-exposure prophylaxis services, voluntary medical male
circumcision services, cervical cancer services, and gender-based
violence services. Other approaches include maternal and child health
services, differentiated HIV service delivery models, and HIV and TB
services.
MISAU is in a unique position to conduct this work, as it is the
central institution of public sector, which according to the law of the
Republic of Mozambique, is responsible for the implementation of health
policy in the public, private, and community domains. MISAU, by law,
has the authority to lead, provide oversight, monitor the
implementation of healthcare programs and services at national level,
and is mandated to develop policies and guidelines, and plan, manage,
and coordinate all health-related activities including HIV/TB services.
Summary of the Award
Recipient: Ministry of Health of Mozambique (MISAU).
Purpose of the Award: The purpose of this award is to to prepare
MISAU to sustain the gains of the national HIV response through the
development of a measurable roadmap for sustainability and support the
Government of Mozambique through MISAU to continue to address HIV/TB as
a public health problem through the expansion of access to quality HIV
prevention, care, and treatment services to reduce remaining gaps among
children, adolescents, KP, and men.
Amount of Award: For MISAU, the approximate year 1 funding amount
will be $10,000,000 in Federal Fiscal Year (FYY) 2024 funds, subject to
the availability of funds. Funding amounts for years 2-5 will be set at
continuation.
Authority: This program is authorized under Public Law 108-25 (the
United States Leadership Against HIV AIDS, Tuberculosis and Malaria Act
of 2003) [22 U.S.C. 7601, et seq.] and Public Law 110-293 (the Tom
Lantos and Henry J. Hyde United States Global Leadership Against HIV/
AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008), and
Public Law 113-56 (PEPFAR Stewardship and Oversight Act of 2013).
Period of Performance: The period for this award will be September
30, 2024, through September 29, 2029.
Dated: March 13, 2024.
Jamie Legier,
Acting Director, Office of Grants Services, Centers for Disease Control
and Prevention.
[FR Doc. 2024-05778 Filed 3-18-24; 8:45 am]
BILLING CODE 4163-18-P
